SOX2 Recombinant Antibody [PO00-28] - Chicken IgY (Chimeric) - BSA and Azide free
cat.: HA610329
Product Type: Recombinant Chimeric Antibody IgY, primary antibodies
Species reactivity: Human, Mouse
Applications: IHC-Fr, WB
Clone number: PO00-28
Form: Liquid
Storage condition: Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.
Storage buffer: 1*PBS (pH7.4).
Concentration: 1ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 34 kDa
Isotype: IgY
Immunogen: Recombinant protein within human SOX2 aa 1-317.
Positive control: Mouse cerebral cortex, NCCIT cell lysate, F9 cell lysate.
Subcellular location: Nucleus.
Recommended Dilutions:
  IHC-Fr
  WB

1:200
1:5,000
Uniprot #: SwissProt: P48431 Human | P48432 Mouse
Alternative names: ANOP3 cb236 Delta EF2a lcc MCOPS3 MGC148683 MGC2413 RGD1565646 Sex determining region Y box 2 SOX 2 Sox2 SOX2_HUMAN SRY (sex determining region Y) box 2 SRY box containing gene 2 SRY related HMG box 2 SRY related HMG box gene 2 SRY-box 2 Transcription factor SOX 2 Transcription factor SOX-2 ysb
Images
HA610329_1.jpg Fig1: Application: IHC-Fr

Species: Mouse

Site: cerebral cortex

Sample: Frozen section

Antibody concentration: 1/200

Antigen retrieval: Not required
HA610329_2.jpg Fig2: Western blot analysis of SOX2 on different lysates with Chicken anti-SOX2 antibody (HA610329) at 1/5,000 dilution.

Lane 1: NCCIT cell lysate
Lane 2: F9 cell lysate

Lysates/proteins at 15 µg/Lane.

Predicted band size: 34 kDa
Observed band size: 36 kDa

Exposure time: 40 seconds; ECL: K1801;

4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA610329) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Chicken IgY - HRP Secondary Antibody (HA1046) at 1/50,000 dilution was used for 1 hour at room temperature.
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.